Combination of Osimertinib and Aspirin to Treat Osimertinib Resistance Non-small Cell Lung Cancer ( NSCLC)

Conditions

• Non-Small Cell Lung Cancer Stage IIIB
• Non-small Cell Lung Cancer Stage IV
• EGFR T790M

Interventions

• DRUG: Aspirin
• DRUG: Osimertinib

Sponsor

Daping Hospital and the Research Institute of Surgery of the Third Military Medical University